메뉴 건너뛰기




Volumn 39, Issue SUPPL. 2, 2001, Pages 6-10

Antiandrogen withdrawal in the treatment of hormone-relapsed prostate cancer: Single institutional experience

Author keywords

Antiandrogen withdrawal; Hormone refractory prostate cancer; Prostate cancer treatment

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; FLUTAMIDE; GONADORELIN DERIVATIVE; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN;

EID: 0035104533     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052550     Document Type: Article
Times cited : (10)

References (10)
  • 2
    • 0031739928 scopus 로고    scopus 로고
    • Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer
    • (1998) Eur Urol , Issue.SUPPL. 3 , pp. 18-23
    • Kelly, W.K.1
  • 5
    • 0027203411 scopus 로고
    • Flutamide withdrawal syndrome: Its impact on clinical trials in hormone-refractory prostate cancer
    • (1993) J Clin Oncol , vol.11 , pp. 1566-1573
    • Scher, H.I.1    Kelly, W.K.2
  • 6
    • 0029084601 scopus 로고
    • The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer
    • (1995) Cancer , vol.76 , pp. 1428-1434
    • Small, E.J.1    Srinivas, S.2
  • 9
    • 0030040676 scopus 로고    scopus 로고
    • Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal
    • (1996) J Urol , vol.155 , pp. 620-623
    • Herrada, J.1    Dieringer, P.2    Logothesis, C.J.3
  • 10
    • 0030929675 scopus 로고    scopus 로고
    • Steroid hormone withdrawal syndrome
    • Oesterlin JE (ed): Prostate Specific Antigen: The Best Prostatic Tumor Marker. Philadelphia, Saunders
    • (1997) , pp. 421-431
    • Kelly, W.K.1    Slovin, S.F.2    Scher, H.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.